{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:12:18Z","timestamp":1793369538311,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003400","name":"Ontario Ministry of Research, Innovation and Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006595","name":"Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii","doi-asserted-by":"publisher","award":["PN-III-P4-ID-PCCF-2016\u20130050"],"award-info":[{"award-number":["PN-III-P4-ID-PCCF-2016\u20130050"]}],"id":[{"id":"10.13039\/501100006595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005186","name":"Corporation for National and Community Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005186","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113793","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T01:42:55Z","timestamp":1629682975000},"page":"113793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action"],"prefix":"10.1016","volume":"225","author":[{"given":"Damiano","family":"Tanini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-9440","authenticated-orcid":false,"given":"Simone","family":"Carradori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Capperucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Lupori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susi","family":"Zara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7258-738X","authenticated-orcid":false,"given":"Marta","family":"Ferraroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-4432","authenticated-orcid":false,"given":"Lorenzo","family":"Di Cesare Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Micheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3459-2660","authenticated-orcid":false,"given":"Elena","family":"Lucarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-7192","authenticated-orcid":false,"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113793_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2021.113793_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/ph14020133","article-title":"Monofunctional platinum(II) anticancer agents","volume":"14","author":"Jin","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2021.113793_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202100015","article-title":"Unveiling the potential of transition metal complexes for medicine: translational in situ activation of metal-based drugs from bench to in\u00a0vivo applications","author":"Silva","year":"2021","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2021.113793_bib4","doi-asserted-by":"crossref","first-page":"127219","DOI":"10.1016\/j.bmcl.2020.127219","article-title":"Fluorescent metal-based complexes as cancer probes","volume":"30","author":"de Almeida","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113793_bib5","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2165\/00003495-200363190-00013","article-title":"Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer","volume":"63","author":"Simpson","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2021.113793_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2021.113793_bib7","first-page":"249","article-title":"Management of oxaliplatin-induced peripheral neuropathy","volume":"1","author":"Saif","year":"2005","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.ejmech.2021.113793_bib8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrneurol.2014.211","article-title":"Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain","volume":"10","author":"Sisignano","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2021.113793_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pain.2009.11.015","article-title":"Acetazolamide and midazolam act synergistically to inhibit neuropathic pain","volume":"148","author":"Asiedu","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.113793_bib10","first-page":"395","article-title":"Inhibition of carbonic anhydrase augments GABAA receptor-mediated analgesia via a spinal mechanism of action","volume":"15","author":"Asiedu","year":"2014","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.ejmech.2021.113793_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejmech.2019.05.058","article-title":"Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects","volume":"177","author":"Angeli","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejmech.2018.05.026","article-title":"Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects","volume":"154","author":"Angeli","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113793_bib14","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113793_bib15","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113793_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737175.2016.1193009","article-title":"Carbonic anhydrase inhibition and the management of neuropathic pain","volume":"16","author":"Supuran","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejmech.2021.113793_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuint.2005.08.007","article-title":"Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus","volume":"48","author":"Halmi","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2021.113793_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2011.03.087","article-title":"Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle","volume":"408","author":"Negi","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113793_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-079X.2010.00821.x","article-title":"Melatonin modulates neuroinflammation and Oxidative stress in experimental diabetic neuropathy: effects on NF-kB and Nrf2 cascades","volume":"50","author":"Negi","year":"2011","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2021.113793_bib20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/adsc.201901536","article-title":"Rongalite-promoted on water synthesis of functionalised tellurides and ditellurides","volume":"362","author":"Tanini","year":"2020","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2021.113793_bib21","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1002\/adsc.201800602","article-title":"A\u00a0Straightforward access to stable \u03b2-functionalized alkyl selenols","volume":"360","author":"Tanini","year":"2018","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2021.113793_bib22","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1016\/j.tet.2017.07.061","article-title":"An easy one-step procedure for the synthesis of novel \u03b2-functionalised tellurides","volume":"73","author":"Tanini","year":"2017","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113793_bib23","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1039\/C9NJ02320H","article-title":"Ring opening reactions of heterocycles with selenium and tellurium nucleophiles","volume":"43","author":"Tanini","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib24","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1039\/C9CC02427A","article-title":"Direct biocatalysed synthesis of first sulfur-, selenium- and tellurium- containing L-ascorbyl hybrid derivatives with radical trapping and GPx-like properties","volume":"55","author":"Tanini","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113793_bib25","doi-asserted-by":"crossref","first-page":"104812","DOI":"10.1016\/j.bioorg.2021.104812","article-title":"Synthesis of functionalised organochalcogenides and in\u00a0vitro evaluation of their antioxidant activity","volume":"110","author":"Capperucci","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib26","doi-asserted-by":"crossref","first-page":"111586","DOI":"10.1016\/j.ejmech.2019.111586","article-title":"Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase inhibitors with antitumor activity","volume":"181","author":"Tanini","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bioorg.2018.09.028","article-title":"Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism","volume":"81","author":"Angeli","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bioorg.2017.12.010","article-title":"First evaluation of organotellurium derivatives as carbonic anhydrase I, II, IV, VII and IX inhibitors","volume":"76","author":"Angeli","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib29","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/acsmedchemlett.7b00387","article-title":"Synthesis of novel selenides bearing benzenesulfonamide moieties as carbonic anhydrase I, II, IV, VII, and IX inhibitors","volume":"8","author":"Angeli","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113793_bib30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.bioorg.2019.03.062","article-title":"Sulfur, selenium and tellurium containing amines act as effective carbonic anhydrase activators","volume":"87","author":"Tanini","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib31","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1039\/D0CC00995D","article-title":"Selenolesterase enzyme activity of carbonic anhydrases","volume":"56","author":"Angeli","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113793_bib32","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/adsc.201900168","article-title":"Seleno-Michael reaction of stable functionalised alkyl selenols: a versatile tool for the synthesis of acyclic and cyclic unsymmetrical alkyl and vinyl selenides","volume":"361","author":"Tanini","year":"2019","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2021.113793_bib33","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1039\/C8CC08562E","article-title":"Selenols: a new class of carbonic anhydrase inhibitors","volume":"55","author":"Angeli","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113793_bib34","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1039\/C9NJ00657E","article-title":"Mild and selective silicon-mediated access to enantioenriched 1,2-mercaptoamines and \u03b2-amino arylchalcogenides","volume":"43","author":"Tanini","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib35","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib36","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1021\/acs.jmedchem.0c00636","article-title":"Azidothymidine \"clicked\" into 1,2,3-triazoles: first report on carbonic anhydrase-telomerase dual-hybrid inhibitors","volume":"63","author":"Berrino","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejmech.2019.05.058","article-title":"Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects","volume":"177","author":"Angeli","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejmech.2018.05.026","article-title":"Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects","volume":"154","author":"Angeli","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib39","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib40","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113793_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92928","article-title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in\u00a0vivo","volume":"2","author":"Boyd","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejmech.2021.113793_bib42","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1021\/acs.jmedchem.9b01434","article-title":"1,3-Dipolar cycloaddition, HPLC enantioseparation, and docking studies of saccharin\/isoxazole and saccharin\/isoxazoline derivatives as selective carbonic anhydrase IX and XII inhibitors","volume":"63","author":"D'Ascenzio","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib43","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.3390\/ijms22126363","article-title":"Influence of paclitaxel and doxorubicin therapy of \u00dfIII-tubulin, carbonic anhydrase IX, and survivin in chemically induced breast cancer in female rat","volume":"22","author":"Pastornick\u00e1","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113793_bib44","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/carcin\/bgaa078","article-title":"lncMat2B regulated by severe hypoxia induces cisplatin resistance by increasing DNA damage repair and tumor-initiating population in breast cancer cells","volume":"41","author":"Garc\u00eda-Venzor","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejmech.2021.113793_bib45","doi-asserted-by":"crossref","first-page":"118638","DOI":"10.1016\/j.ijpharm.2019.118638","article-title":"Selenium-doped calcium carbonate nanoparticles loaded with cisplatin enhance efficiency and reduce side effects","volume":"570","author":"Zhao","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2021.113793_bib46","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/molecules24020336","article-title":"Organoselenium compounds as novel adjuvants of chemotherapy drugs-A promising approach to fight cancer drug resistance","volume":"24","author":"Spengler","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113793_bib47","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1002\/ejoc.201701752","article-title":"A\u00a0remarkable influence of a trifluoromethyl group on the reactions of \u03b2-mercaptoalcohols with fluorinated \u03b1-bromoenones","author":"Obijalska","year":"2018","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib48","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1021\/ol100558b","article-title":"An efficient one-pot synthesis of symmetrical diselenides or ditellurides from halides with CuO nanopowder\/Se0 or Te0\/base","volume":"12","author":"Singh","year":"2010","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113793_bib49","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113793_bib50","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1021\/acs.jmedchem.0c00211","article-title":"Tellurides bearing sulfonamides as novel inhibitors of leishmanial carbonic anhydrase with potent antileishmanial activity","volume":"63","author":"Angeli","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib51","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bioorg.2018.11.033","article-title":"Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: dual cyclooxygenase\/carbonic anhydrase inhibitory actions","volume":"84","author":"Abdel-Aziz","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib52","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.fct.2017.08.009","article-title":"Bioactive isoflavones from Pueraria lobata root and starch: different extraction techniques and carbonic anhydrase inhibition","volume":"112","author":"Mocan","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113793_bib53","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/acsmedchemlett.8b00362","article-title":"Heterocoumarins are selective carbonic anhydrase IX and XII inhibitors with cytotoxic effects against cancer cells lines","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113793_bib54","first-page":"2899","article-title":"Induction and testing of hypoxia in cell culture","volume":"54","author":"Wu","year":"2011","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.ejmech.2021.113793_bib55","first-page":"41","article-title":"Procesing diffraction data with mosflm","volume":"vol. 245","author":"Leslie","year":"2007"},{"key":"10.1016\/j.ejmech.2021.113793_bib56","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.ejmech.2021.113793_bib57","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.ejmech.2021.113793_bib58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by C\u03b1 geometry: \u03c6,\u03c8 and C\u03b2 deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2021.113793_bib59","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2021.113793_bib60","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113793_bib61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejphar.2015.10.005","article-title":"Intrathecal administration of nociceptin\/orphanin FQ receptor agonists in rats: a strategy to relieve chemotherapy-induced neuropathic hypersensitivity","volume":"766","author":"Micheli","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113793_bib62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.expneurol.2016.04.022","article-title":"The \u03b19\u03b110 nicotinic receptor antagonist \u03b1-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment","volume":"282","author":"Pacini","year":"2016","journal-title":"Exp. Neurol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:36:17Z","timestamp":1759329377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421006425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":62,"alternative-id":["S0223523421006425"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113793","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113793"}}